145 related articles for article (PubMed ID: 19350236)
1. (18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK).
Hultsch C; Schottelius M; Auernheimer J; Alke A; Wester HJ
Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1469-74. PubMed ID: 19350236
[TBL] [Abstract][Full Text] [Related]
2. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.
Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ
J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641
[TBL] [Abstract][Full Text] [Related]
3. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG.
Namavari M; Cheng Z; Zhang R; De A; Levi J; Hoerner JK; Yaghoubi SS; Syud FA; Gambhir SS
Bioconjug Chem; 2009 Mar; 20(3):432-6. PubMed ID: 19226160
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process.
Pohle K; Notni J; Bussemer J; Kessler H; Schwaiger M; Beer AJ
Nucl Med Biol; 2012 Aug; 39(6):777-84. PubMed ID: 22444238
[TBL] [Abstract][Full Text] [Related]
5. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
[TBL] [Abstract][Full Text] [Related]
6. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression.
Decristoforo C; Hernandez Gonzalez I; Carlsen J; Rupprich M; Huisman M; Virgolini I; Wester HJ; Haubner R
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1507-15. PubMed ID: 18369617
[TBL] [Abstract][Full Text] [Related]
7. Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptor.
Dall'Angelo S; Zhang Q; Fleming IN; Piras M; Schweiger LF; O'Hagan D; Zanda M
Org Biomol Chem; 2013 Jul; 11(27):4551-8. PubMed ID: 23733207
[TBL] [Abstract][Full Text] [Related]
8. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.
Maschauer S; Haubner R; Kuwert T; Prante O
Mol Pharm; 2014 Feb; 11(2):505-15. PubMed ID: 24325589
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and biodistribution of a prosthetic group (¹⁸F-FENMA) conjugated to cyclic RGD peptides.
Olberg DE; Cuthbertson A; Solbakken M; Arukwe JM; Qu H; Kristian A; Bruheim S; Hjelstuen OK
Bioconjug Chem; 2010 Dec; 21(12):2297-304. PubMed ID: 21070000
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
11. Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.
Notni J; Pohle K; Wester HJ
Nucl Med Biol; 2013 Jan; 40(1):33-41. PubMed ID: 22995902
[TBL] [Abstract][Full Text] [Related]
12. First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies.
Chin FT; Shen B; Liu S; Berganos RA; Chang E; Mittra E; Chen X; Gambhir SS
Mol Imaging Biol; 2012 Feb; 14(1):88-95. PubMed ID: 21400112
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
14. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.
Haubner R; Kuhnast B; Mang C; Weber WA; Kessler H; Wester HJ; Schwaiger M
Bioconjug Chem; 2004; 15(1):61-9. PubMed ID: 14733584
[TBL] [Abstract][Full Text] [Related]
15. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
16. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
[TBL] [Abstract][Full Text] [Related]
20. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
